drugset / Trial / NCT00425490

Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus

NCT00425490

Phase 3 Completed 30 enrolled Sheba Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The study is designed to investigate the effect of 18 weeks treatment with Sitagliptin 100 mg/day on the insulin secretion capacity of beta cells. Patients who meet the study enrollment criteria will undergo 2 experiments (see description below); a graded hyperglycemic technique and a meal test, prior to randomization and after a 12-wk double-blind study period. The treatment effect will shed light on the magnitude of the beta cell capacity to increase its mass and function.

Timeline

Start
2007-01
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 100 mg